FT Big Read

Fighting cancer: Rocky path for immunotherapy

FT Big Read

High hopes that new immunotherapy drugs would prove to have benefits over toxic chemotherapy were dashed by large-scale trials, says David Crow. Pharmaceutical groups are now working on combinations of the immunotherapies and using them with chemo, but some pharma groups have suffered big losses and Wall Street has become sceptical

Hosted on Acast. See acast.com/privacy for more information.

Next Episodes

FT Big Read

Nafta: Trade deal in Trump's sights @ FT Big Read

📆 2017-01-31 13:49 / 00:11:20


FT Big Read

Indonesia: A trial of tolerance @ FT Big Read

📆 2017-01-26 15:51 / 00:13:25


FT Big Read

Toshiba: Falling star @ FT Big Read

📆 2017-01-19 20:05 / 00:13:17


FT Big Read

Wall Street: The path ahead under President Trump @ FT Big Read

📆 2017-01-13 17:45 / 00:14:52


FT Big Read

Martin Wolf: The west's global order unravels @ FT Big Read

📆 2017-01-05 15:42 / 00:15:44